Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
https://www.zacks.com/stock/news/2272308/ironwood-irwd-q1-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2272308
May 10, 2024 - Ironwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss estimates. The company lowers revenue guidance for 2024. Stock falls.
0
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
https://www.zacks.com/stock/news/2245547/opko-health-opk-and-entera-bio-announce-data-for-glp-2?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245547
Mar 25, 2024 - OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
0
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
https://www.zacks.com/stock/news/2227354/ironwood-irwd-q4-earnings-miss-revenues-beat-marginally?cid=CS-ZC-FT-analyst_blog|earnings_article-2227354
Feb 16, 2024 - Ironwood's (IRWD) fourth-quarter 2023 earnings lag estimates while revenues beat the same marginally. Linzess collaboration revenues drive the top line.
0
Pages: 1
Page 1